Deltaaminogamma-hydroxy-omega-aryl-alkanoic acid amides and use as renin inhibitors

Details for Australian Patent Application No. 2004295093 (hide)

Owner Novartis AG

Inventors Sellner, Holger; Maibaum, Juergen Klaus; Gross, Gerhard; Cottens, Sylvain

Agent Davies Collison Cave

Pub. Number AU-B-2004295093

PCT Pub. Number WO2005/054177

Priority 0327839.7 01.12.03 GB

Filing date 30 November 2004

Wipo publication date 16 June 2005

Acceptance publication date 14 August 2008

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

C07C 237/22 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/054177 Priority application(s): WO2005/054177

14 August 2008 Application Accepted

  Published as AU-B-2004295093

11 December 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295104-GAG binding proteins

2004295092-Azabicyclooctene and other tetrahydropyridine derivatives with a new sidechain